文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新型冠状病毒肺炎与血管紧张素转换酶 2 的关系:范围综述。

Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.

机构信息

Student Research Committee, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Adv Exp Med Biol. 2021;1321:53-68. doi: 10.1007/978-3-030-59261-5_5.


DOI:10.1007/978-3-030-59261-5_5
PMID:33656713
Abstract

Following the outbreaks of SARS-CoV in 2002 and MERS-CoV in 2012, the COVID-19 pandemic caused by the SARS-CoV-2 virus has become an increasing threat to human health around the world. Numerous studies have shown that SARS-CoV-2 appears similar to the SARS-CoV as it uses angiotensin converting enzyme 2 (ACE2) as a receptor to gain entry into cells. The main aims of this scoping review were to identify the primary hosts of coronaviruses, the relationship between the receptor binding domain of coronaviruses and ACE2, the organ specificity of ACE2 expression compared with clinical manifestations of the disease, and to determine if this information can be used in the development of novel treatment approaches for the COVID-19 pandemic.

摘要

继 2002 年 SARS-CoV 和 2012 年 MERS-CoV 爆发后,由 SARS-CoV-2 病毒引起的 COVID-19 大流行已成为全球人类健康的日益威胁。大量研究表明,SARS-CoV-2 与 SARS-CoV 相似,因为它使用血管紧张素转换酶 2(ACE2)作为受体进入细胞。本范围综述的主要目的是确定冠状病毒的主要宿主,冠状病毒的受体结合域与 ACE2 的关系,ACE2 表达与疾病临床表现的器官特异性,并确定这些信息是否可用于开发针对 COVID-19 大流行的新型治疗方法。

相似文献

[1]
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.

Adv Exp Med Biol. 2021

[2]
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.

J Virol. 2020-8-31

[3]
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.

J Med Virol. 2020-4-5

[4]
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.

Proc Natl Acad Sci U S A. 2021-3-23

[5]
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.

Theranostics. 2020-6-12

[6]
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.

J Med Virol. 2020-3-11

[7]
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

J Virol. 2020-3-17

[8]
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.

mSphere. 2020-9-16

[9]
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.

Hypertension. 2020-8-27

[10]
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.

Nature. 2013-10-30

引用本文的文献

[1]
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern.

Vaccines (Basel). 2022-4-8

[2]
COVID-19 and the liver: What do we know so far?

World J Hepatol. 2021-5-27

[3]
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins.

Viruses. 2021-4-6

本文引用的文献

[1]
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.

N Z Med J. 2020-5-22

[2]
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?

PLoS Pathog. 2020-5-14

[3]
Gastrointestinal and Liver Manifestations of COVID-19.

J Clin Exp Hepatol. 2020

[4]
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.

Cardiovasc Pathol. 2020-4-17

[5]
COVID-19 pathophysiology: A review.

Clin Immunol. 2020-4-20

[6]
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.

PLoS One. 2020-4-16

[7]
The proximal origin of SARS-CoV-2.

Nat Med. 2020-4

[8]
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].

Zhongguo Zhong Yao Za Zhi. 2020-3

[9]
Coronavirus disease 2019 (COVID-19): current status and future perspectives.

Int J Antimicrob Agents. 2020-3-29

[10]
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Cell. 2020-3-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索